Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,919 | -101,878 | -70,880 | -37,367 | -90,872 |
| Depreciation Amortization | 2,990 | 2,393 | 1,674 | 891 | 3,748 |
| Other Working Capital | 8,882 | 3,635 | 7,363 | 481 | -7,847 |
| Other Operating Activity | 10,170 | 7,739 | 5,272 | 2,829 | 11,477 |
| Operating Cash Flow | $-28,877 | $-88,111 | $-56,571 | $-33,166 | $-83,494 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,928 | -24,928 | -24,928 | -24,928 | -130,272 |
| PPE Investments | -919 | -696 | -456 | -107 | -373 |
| Sale Of Investment | 109,325 | 94,875 | 63,725 | 22,675 | 70,131 |
| Investing Cash Flow | $83,478 | $69,251 | $38,341 | $-2,360 | $-60,514 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 442 | 442 | 442 | 409 | 92,044 |
| Financing Cash Flow | $442 | $442 | $442 | $409 | $92,044 |
| Beginning Cash Position | 96,799 | 96,799 | 96,799 | 96,799 | 148,763 |
| End Cash Position | 151,842 | 78,381 | 79,011 | 61,682 | 96,799 |
| Net Cash Flow | $55,043 | $-18,418 | $-17,788 | $-35,117 | $-51,964 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,877 | -88,111 | -56,571 | -33,166 | -83,494 |
| Capital Expenditure | -919 | -696 | -456 | -107 | -373 |
| Free Cash Flow | -29,796 | -88,807 | -57,027 | -33,273 | -83,867 |